Skip to content

"Effect of Pre-Spinal Mindfulness-Based Breathing Exercise on Hemodynamic Response in Elective Cesarean Section"

"The Effect of a 5-Minute Mindfulness-Based Breathing Exercise Administered Prior to Spinal Anesthesia on Hemodynamic Response in Patients Undergoing Elective Cesarean Section: A Prospective Randomized Controlled Trial"

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07494955
Acronym
BREATHE-CS
Enrollment
150
Registered
2026-03-27
Start date
2026-03-01
Completion date
2028-03-01
Last updated
2026-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Anticipatory, Cesarean Section, Hemodynamic Instability, Hypotension

Keywords

Spinal anesthesia, Hypotension, Cesarean section, Mindfulness, Breathing exercise, Hemodynamic response, Preoperative anxiety, Autonomic nervous system, Obstetric anesthesia, Vasopressor, Systolic blood pressure, Heart rate variability, Non-pharmacological intervention, Randomized controlled trial, Baroreflex sensitivity

Brief summary

Spinal anesthesia-induced hypotension is one of the most frequent and clinically significant complications of obstetric anesthesia, occurring in up to 50-80% of parturients undergoing elective cesarean section. Preoperative anxiety has been shown to potentiate hemodynamic instability through autonomic nervous system activation, thereby increasing susceptibility to spinal hypotension. This prospective, randomized, controlled trial aims to evaluate the effect of a standardized 5-minute mindfulness-based breathing exercise administered immediately prior to spinal anesthesia on the hemodynamic response in pregnant women scheduled for elective cesarean section. Eligible participants will be randomized in a 1:1 ratio into two parallel groups: the Mindfulness-Based Breathing Exercise Group and the Control Group receiving standard preoperative care. The breathing intervention consists of slow diaphragmatic breathing at a rate of approximately 6 breaths per minute (4-second inhalation through the nose, 6-second exhalation through the mouth), guided by a standardized script delivered by a trained anesthesiologist or nurse. Participants in the intervention group will be instructed to silently repeat the phrase "My body is relaxing as I exhale" with each exhalation, incorporating a mindfulness component. The primary outcome is the maximum decrease in systolic arterial pressure (SAP) within the first 10 minutes following spinal anesthesia induction. Secondary outcomes include preoperative state anxiety scores (STAI-5), early spinal hypotension incidence, heart rate changes, and vasopressor requirements. The study will be conducted at Atatürk University Faculty of Medicine, Department of Anesthesiology and Reanimation, Erzurum, Turkey, in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines.

Detailed description

Background and Rationale Spinal anesthesia-induced hypotension is the most common hemodynamic complication in obstetric anesthesia, with reported incidence rates ranging from 50% to 80% in parturients undergoing elective cesarean section. The underlying pathophysiology involves sympathetic blockade-mediated arteriolar and venous vasodilation, resulting in decreased systemic vascular resistance and reduced venous return, further compounded by aortocaval compression exerted by the gravid uterus. Current prophylactic strategies including left uterine displacement, fluid co-loading, and vasopressor infusion remain the standard of care. However, these pharmacological approaches may be associated with tachycardia, hypertension, and inter-individual response variability, underscoring the need for complementary non-pharmacological interventions. Preoperative anxiety exerts measurable effects on autonomic nervous system balance, potentially amplifying sympathetic tone and increasing hemodynamic instability following neuraxial blockade. Slow, controlled breathing exercises have been shown to enhance baroreflex sensitivity and augment parasympathetic vagal activity, suggesting that a brief mindfulness-based breathing intervention may attenuate sympathetic hyperactivity through an "autonomic preconditioning" mechanism. Randomization and Allocation Concealment Participants will be randomized in a 1:1 ratio using a computer-generated random number sequence. Allocation concealment will be ensured through sequentially numbered, opaque, sealed envelopes (SNOSE), opened only after the patient has been transferred to the operating room and immediately before spinal anesthesia induction. Intervention Protocol Participants in the intervention arm will receive a 5-minute guided mindfulness-based breathing exercise prior to spinal anesthesia, consisting of slow diaphragmatic breathing at approximately 6 breaths per minute (4-second nasal inhalation, 6-second oral exhalation). During each exhalation, participants silently repeat: "My body is relaxing as I exhale." Anesthesia Management All participants will receive spinal anesthesia in the sitting position with intrathecal administration of 11.2 mg hyperbaric bupivacaine + 15 mcg fentanyl + 150 mcg morphine. Hypotension will be defined as a decrease in systolic arterial pressure (SAP) exceeding 20% from baseline and treated with norepinephrine or ephedrine. Bradycardia will be defined as heart rate ≤50 bpm and treated with intravenous atropine (1 mg). Statistical Analysis All analyses will be performed using IBM SPSS Statistics (Statistical Package for the Social Sciences) version 20. Normality will be assessed using Shapiro-Wilk and Kolmogorov-Smirnov tests. Between-group comparisons will be performed using independent samples t-test or Mann-Whitney U test as appropriate. Categorical variables will be compared using chi-square test. Statistical significance will be set at p\<0.05. Sample Size Sample size was calculated using G\*Power 3.1.9.7 software. A clinically meaningful difference of 4.5 mmHg in maximum SAP decrease (effect size = 0.48) was determined to require 70 participants per group at 80% power and 95% confidence level. Accounting for potential dropout, 150 participants (75 per group) will be enrolled.

Interventions

"A standardized 5-minute mindfulness-based breathing exercise at approximately 6 breaths per minute (4-second nasal inhalation, 6-second oral exhalation), guided by a trained anesthesiologist or nurse using a standardized verbal script. During each exhalation, participants silently repeat: 'My body is relaxing as I exhale.'"

Sponsors

Aysenur Dostbil
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Masking description

Due to the nature of the intervention, blinding of participants and care providers is not feasible in this trial. However, outcome assessor blinding will be implemented to minimize measurement bias. Hemodynamic data (systolic arterial pressure, heart rate, and peripheral oxygen saturation) will be recorded prospectively by a designated investigator who is blinded to group allocation and has no involvement in the administration of the breathing exercise or the randomization process. This single-blind design ensures that primary and secondary hemodynamic outcome measurements are obtained independently of treatment assignment, thereby reducing the risk of assessment bias.

Intervention model description

This study employs a two-arm parallel-group design in which eligible participants are randomly assigned in a 1:1 ratio to either the Mindfulness-Based Breathing Exercise Group or the Control Group. Participants in the intervention arm receive a standardized 5-minute mindfulness-based breathing exercise immediately prior to spinal anesthesia induction, while participants in the control arm receive standard preoperative care without any breathing or relaxation intervention. Each participant is assigned to one group only, with no crossover between arms. Randomization is performed using a computer-generated random number sequence with allocation concealment ensured through sequentially numbered, opaque, sealed envelopes (SNOSE).

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

Pregnant women aged 18-45 years Singleton pregnancy Gestational age 37 weeks or greater American Society of Anesthesiologists (ASA) physical status classification II Scheduled for elective cesarean section under spinal anesthesia Body mass index (BMI) 35 kg/m2 or less Ability to comprehend verbal instructions and perform the breathing exercise Provision of written informed consent

Exclusion criteria

Emergency cesarean section Hypertensive disorders of pregnancy (gestational hypertension, preeclampsia, eclampsia, HELLP syndrome) Placenta previa, placental abruption, or active antepartum hemorrhage Multiple pregnancy Contraindications to spinal anesthesia Failed spinal anesthesia requiring conversion to general anesthesia Chronic hypertension or chronic hypotension Known cardiac disease (arrhythmia, valvular disease, cardiomyopathy) Diabetes mellitus with autonomic neuropathy Thyroid dysfunction Chronic pulmonary disease potentially affecting respiratory pattern Body mass index greater than 35 kg/m2 Regular use of beta-blockers, calcium channel blockers, alpha-agonists, or alpha-antagonists Regular use of anxiolytics, antidepressants, sedatives, or chronic opioids Diagnosed anxiety disorder, panic disorder, major depressive disorder, or other psychiatric illness Regular use of psychiatric medications Cognitive impairment or communication difficulties Attention or compliance problems precluding adequate performance of the breathing exercise Prior regular practice of meditation, yoga, or mindfulness-based training

Design outcomes

Primary

MeasureTime frameDescription
Maximum Decrease in Systolic Arterial Pressure (ΔSAP_max) Following Spinal AnesthesiaUp to 10 minutes following spinal anesthesia induction"he primary outcome is the maximum decrease in systolic arterial pressure (SAP) within the first 10 minutes following spinal anesthesia induction, calculated as the difference between the SAP value measured immediately prior to spinal anesthesia (T1, reference value) and the lowest SAP value recorded during the first 10 minutes post-spinal (SAP\_min). Formula: ΔSAP\_max = SAP\_T1 - SAP\_min (mmHg). SAP will be measured non-invasively at 1-minute intervals during the first 10 minutes following spinal induction.

Secondary

MeasureTime frameDescription
Change in Preoperative State Anxiety Score (ΔSTAI-S5)"Baseline and up to 5 minutes prior to spinal anesthesia induction"Change in state anxiety level assessed using the validated Turkish short form of the Spielberger State-Trait Anxiety Inventory (STAI-S5), a 5-item scale scored on a 4-point Likert scale (total score range: 5-20; higher scores indicate greater anxiety). The change score will be calculated as the difference between STAI-S5 scores measured immediately before (T0) and immediately after (T1) the 5-minute breathing exercise.
Incidence of Early Spinal Hypotension"Up to 10 minutes following spinal anesthesia induction"Proportion of participants developing hypotension, defined as a decrease in systolic arterial pressure exceeding 20% from baseline, within the first 5 minutes and within the first 10 minutes following spinal anesthesia induction. Reported as the ratio of patients experiencing hypotension to the total number of patients per group.
Maximum Heart Rate Decrease (ΔHR_max) Following Spinal Anesthesia"Up to 10 minutes following spinal anesthesia induction": Maximum decrease in heart rate within the first 10 minutes following spinal anesthesia induction, calculated as the difference between the heart rate measured immediately prior to spinal anesthesia (T1, reference value) and the lowest heart rate recorded during the first 10 minutes post-spinal (HR\_min). Formula: ΔHR\_max = HR\_T1 - HR\_min (beats per minute).
Time to First Hypotensive Episode"During surgery, up to approximately 60 minutes following spinal anesthesia induction"Time elapsed (in minutes) from spinal anesthesia induction to the first recorded hypotensive episode, defined as a decrease in systolic arterial pressure exceeding 20% from baseline value (T1).
Proportion of Participants Requiring Vasopressor Therapy"Up to 10 minutes following spinal anesthesia induction"Proportion of participants in each group requiring administration of norepinephrine or ephedrine for the treatment of spinal anesthesia-induced hypotension within the first 10 minutes following spinal induction. Reported as percentage of patients per group.
Total Vasopressor Dose Administered"Up to 10 minutes following spinal anesthesia induction"Total cumulative dose (in micrograms for norepinephrine; in milligrams for ephedrine) of vasopressor agents administered within the first 10 minutes following spinal anesthesia induction for the treatment of hypotension.
Lowest Systolic Arterial Pressure (SAP_min) Following Spinal Anesthesia"Up to 10 minutes following spinal anesthesia induction"The lowest systolic arterial pressure value (mmHg) recorded within the first 10 minutes following spinal anesthesia induction, measured by non-invasive blood pressure monitoring at 1-minute intervals.

Countries

Turkey (Türkiye)

Contacts

CONTACTesra dilara ayber, MD
esraayber@hotmail.com+905077794216
CONTACTaysenur dostbil, PROF. DR.
adostbil@hotmail.com+905333676696
STUDY_DIRECTORkamber kaşali

Atatürk University Faculty of Medicine, Department of Biostatistics, Erzurum, Turkey

STUDY_DIRECTORgamze nur cimilli şenocak, MD

Atatürk University Faculty of Medicine, Department of Obstetrics and Gynecology, Erzurum, Turkey

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 2, 2026